Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
about
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma.Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancerPrognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapyPrognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma.Modelling prognostic factors in advanced pancreatic cancerPrognostic value of patient-reported symptom interference in patients with late-stage lung cancerMultimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicineThe Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy.Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review.Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer.Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective series.The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer.
P2860
Q33394190-64C53698-54DA-4A1F-8DF3-515AA4DFD5EEQ33489063-4BD5CC9C-9414-4527-A777-8C341F5B5D15Q34636501-9661F662-3397-4C10-A812-83995850F125Q34669394-5CDA05F3-0EC8-4F44-9027-2F2F1637409AQ35968248-2F041A52-7F37-40D9-93B1-09C27298BB90Q36561493-C601F3F6-AE79-409A-9035-CBBADD6E5E99Q36637079-26E072F6-40CD-480F-951A-0EFA66B7EA47Q36882688-2B451DE6-0E3C-4FDF-87AF-76F1EBCAAE9EQ37048771-DA3133C7-9755-4334-9288-DE51455650EAQ37120362-410B8448-15CE-48EC-847F-E01B36FC0497Q37710295-560A1F47-AEAF-4260-B8DD-37955BAB7EEEQ37711653-0A478EAB-06C1-4F1A-8273-A53B8DC35DAEQ38018315-CD0E4C5F-DB0C-45DD-A950-8BC29880A619Q39740700-D90052F6-2695-4BF8-BC01-9DA5FCE7F640Q40114557-034B091A-6B73-4467-B12E-97FFD5C16600Q41963194-C06A346F-3A84-4DF1-B713-BFEBBD463E8EQ42238114-DB9620A7-5217-46FA-81B7-335636957A9BQ45386745-4D6E9C96-3421-4AAF-AA72-98A3BC73A873Q46601897-7ABD2FC3-1BB4-4FB6-99EE-7827F1E387A8Q47891073-CD2A23BE-3D4D-418B-B8D9-009214329967Q50176866-32773D7B-8E61-417D-98E8-C51DCDA39544Q51266754-5F090C17-D807-4335-9AF1-FE24A25EDDDA
P2860
Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@ast
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@en
type
label
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@ast
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@en
prefLabel
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@ast
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@en
P2093
P2860
P1433
P1476
Prognostic factors in patients ...... a receiving chemoradiotherapy.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010201)91:3<490::AID-CNCR1027>3.0.CO;2-L
P407
P577
2001-02-01T00:00:00Z